Literature DB >> 4038470

Role of ligand exchange processes in the reaction kinetics of the antitumor drug cis-diamminedichloroplatinum(II) with its targets.

E Segal, J B Le Pecq.   

Abstract

The kinetics of a model reaction between the antitumor drug cis-diamminedichloroplatinum(II)(cis-DDP) and the signal nucleotide diadenosine 5',5"'-P1,P4-tetraphosphate (Ap4A) has been investigated by spectrophotometry. The formation of the reactive platinum aquated species was first analyzed by potentiometry using a chloride-specific electrode. Both equilibrium and rate constants were measured. The rate constants for the release of the first and second chloride were found 1.1 +/- 0.5 (S.D.) X 10(-4) and 4.2 +/- 0.2 X 10(-5) sec-1, respectively, at 37 degrees. It was shown that anions such as acetate, phosphate, and pyrophosphate were able, in some conditions, to exchange with chloride to form acetato, phosphato, or pyrophosphato complexes. The reaction of cis-DDP with Ap4A or other targets involves at least four steps, which have been analyzed separately. The values of rate constants deduced from the analysis of the overall reaction are in agreement with those determined independently from the separated steps. The second-order rate constants for the reaction of acetato, phosphato, and pyrophosphato complexes with Ap4A (0.2 +/- 0.02, 0.20 +/- 0.02, and 0.16 +/- 0.03 M-1 sec-1, respectively) are close to that of monoaqua-monochloro (0.16 +/- 0.1 M-1 sec-1) and lower than that of the diaqua species (0.94 +/- 0.06 M-1 sec-1). At a high concentration of Ap4A, the reaction kinetics is slowed down. The formation of a complex of cis-platinum with the Ap4A phosphate groups is suggested. The intracellular concentration of phosphates, pyrophosphates, and carboxylates is large enough to displace chloride from cis-DDP. Inside cells, therefore, ligand exchange processes have to be taken into account to analyze the in vivo reactivity of cis-DDP with its potential targets.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4038470

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.

Authors:  C L King; S Ramachandran; S G Chaney; L Collins; J A Swenberg; K E DeKrafft; W Lin; L Cicurel; M Barbier
Journal:  Cancer Chemother Pharmacol       Date:  2011-10-04       Impact factor: 3.333

2.  Core cross-linked block ionomer micelles as pH-responsive carriers for cis-diamminedichloroplatinum(II).

Authors:  Hardeep S Oberoi; Frederic C Laquer; Luis A Marky; Alexander V Kabanov; Tatiana K Bronich
Journal:  J Control Release       Date:  2011-04-08       Impact factor: 9.776

3.  Understanding the effect of carbonate ion on cisplatin binding to DNA.

Authors:  Ryan C Todd; Katherine S Lovejoy; Stephen J Lippard
Journal:  J Am Chem Soc       Date:  2007-04-28       Impact factor: 15.419

4.  Monofunctional DNA-platinum(II) adducts block frequently DNA polymerases.

Authors:  E Holler; R Bauer; F Bernges
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

5.  Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNA.

Authors:  C Pérez; M Leng; J M Malinge
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

6.  Reactivity of monofunctional cis-platinum adducts as a function of DNA sequence.

Authors:  J M Malinge; M Leng
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

7.  LHRH-targeted nanogels as a delivery system for cisplatin to ovarian cancer.

Authors:  Natalia V Nukolova; Hardeep S Oberoi; Yi Zhao; Vladimir P Chekhonin; Alexander V Kabanov; Tatiana K Bronich
Journal:  Mol Pharm       Date:  2013-08-30       Impact factor: 4.939

Review 8.  Platinum antitumour agents: a review of (bio)analysis.

Authors:  T J Hodes; W J Underberg; G Los; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

Review 9.  Evolution of high-dose cisplatin.

Authors:  W M Holleran; M W DeGregorio
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850

10.  Phosphodiester-mediated reaction of cisplatin with guanine in oligodeoxyribonucleotides.

Authors:  Meghan A Campbell; Paul S Miller
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.